Mid Europa Partners private equity investor in Central and Eastern Europe, has announced today the agreement to sell Walmark a.s. to STADA Arzneimittel AG. The transaction is subject to customary competition authority clearance and is expected to close in Q1 2020.
Walmark pharma company is present in nine European Union countries.
Matthew Strassberg, Co-Managing Partner of Mid Europa commented: “The acquisition by STADA validates Walmark’s successful transformation from a family-led business to a professionalised international platform. Working in partnership with new management team, we have achieved our original vision for the Company and created a valuable strategic asset by developing and implementing a thorough approach to operational excellence and focused product innovation. We would like to thank Walmark management and employees for their dedication and contribution over the past several years. Mid Europa’s investment in Walmark and other market-leading businesses, such as Profi, Regina Maria, and Urgent Cargus, illustrate our continuing track record of successful partnerships with exceptional management teams and entrepreneurs across our region”.
Miro Slezak, CEO of Walmark, said in his turn: “This transaction recognizes the value of Walmark’s unique brands as well as strong organization attracting some of the best talent across our markets. We are very pleased to be joining STADA, as we share a common purpose of supporting our customers to live healthier lives and we are excited for the new opportunities for our employees as part of a larger company. We are grateful for Mid Europa’s support and strong commitment to the Company’s long-term strategy throughout their investment”.